東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Impact of Corporate Social Responsib...

Adamu, Stephen A.

Linked to FindBook

Google Book

Amazon

博客來

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry./
Author:	Adamu, Stephen A.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2017,
Description:	198 p.
Notes:	Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.
Contained By:	Dissertation Abstracts International79-04B(E).
Subject:	Pharmaceutical sciences. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10689996
ISBN:	9780355548822

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
Adamu, Stephen A.

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry. - Ann Arbor : ProQuest Dissertations & Theses, 2017 - 198 p.

Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.

Thesis (Ed.D.)--Pepperdine University, 2017.

Many studies have examined the association between corporate social responsibility (CSR) and corporate financial performance, but scholars argue that the exact relationship between CSR and corporate financial performance remains unclear. This quantitative study examines the impact of CSR on corporate financial performance in the pharmaceutical industry. The study addresses the research question: What is the financial performance in the pharmaceutical industry among companies that have embraced CSR? The alternative hypothesis predicted positive correlations between financial performance and CSR. The related null hypotheses predicted that there would be no correlations between any of 8 dimensions of CSR and corporate financial performance. Archival data from 18 leading global pharmaceutical companies ranked by Access to Medicine Index were used to answer the research question.

ISBN: 9780355548822Subjects--Topical Terms:

3173021
Pharmaceutical sciences.

Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
LDR:03427nmm a2200325 4500 001 2155757
005 20180511093035.5
008 190424s2017 ||||||||||||||||| ||eng d
020 $a 9780355548822
035 $a (MiAaPQ)AAI10689996
035 $a (MiAaPQ)pepperdinegsep:10982
035 $a AAI10689996
040 $a MiAaPQ $c MiAaPQ
100 1 $a Adamu, Stephen A. $3 3343494
245 1 0 $a Impact of Corporate Social Responsibility on Financial Performance in the Pharmaceutical Industry.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2017
300 $a 198 p.
500 $a Source: Dissertation Abstracts International, Volume: 79-04(E), Section: B.
500 $a Adviser: James Rocco DellaNeve.
502 $a Thesis (Ed.D.)--Pepperdine University, 2017.
520 $a Many studies have examined the association between corporate social responsibility (CSR) and corporate financial performance, but scholars argue that the exact relationship between CSR and corporate financial performance remains unclear. This quantitative study examines the impact of CSR on corporate financial performance in the pharmaceutical industry. The study addresses the research question: What is the financial performance in the pharmaceutical industry among companies that have embraced CSR? The alternative hypothesis predicted positive correlations between financial performance and CSR. The related null hypotheses predicted that there would be no correlations between any of 8 dimensions of CSR and corporate financial performance. Archival data from 18 leading global pharmaceutical companies ranked by Access to Medicine Index were used to answer the research question.
520 $a In 4 of the 8 hypotheses tested, the results show partial support for a positive effect of CSR on corporate financial performance in the pharmaceutical industry based on significant correlations in 2014. Specifically, significant 2014 relationships with corporate financial performance were observed for CSR general access to medicine management, CSR capacity advancement in product development and distribution, CSR product donations and philanthropic activities, and overall CSR. However, no significant 2014 relationships with corporate financial performance were observed for CSR public policy and market influence, CSR research and development, CSR pricing, manufacturing, and distribution, and CSR patents and licensing. In the 8 hypotheses tested, the findings in 2012 did not show any effect of CSR on corporate financial performance in the pharmaceutical industry. The results of this study suggest at the minimum, that CSR does not negatively impact corporate financial performance in the pharmaceutical industry. This study does not support arguments against product donations and philanthropic activities. The partial support for a positive effect of CSR on corporate financial performance and no negative impact of CSR on financial performance in the pharmaceutical industry, could encourage corporate leaders to pay attention to, not only their corporate financial profits, but also ethical, environmental, and social issues such as improving the access to medicines; and contributing to improving society.
590 $a School code: 6009.
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Public health. $3 534748
650 4 $a Finance. $3 542899
690 $a 0572
690 $a 0573
690 $a 0508
710 2 $a Pepperdine University. $b Education. $3 1019295
773 0 $t Dissertation Abstracts International $g 79-04B(E).
790 $a 6009
791 $a Ed.D.
792 $a 2017
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10689996